Unichem gets USFDA nod for API facility at Pithampur

Posted on: November 10, 2009 at 3:13 pm

Unichem Laboratories, a leading pharmaceutical company today announced that it has received approval for its bulk drug [active pharmaceutical ingredients (API)] facility situated at Pithampur from US Food and Drug Administration (USFDA).
With this approval, both bulk drug facilities situated at Roha, Maharashtra and Pithampur, Madhya Pradesh are duly approved by US FDA.
The company`s formulation facilities [...]

For Full Story Click Here ...



Zydus Pharma gets USFDA nod for Ramipril tablets

Posted on: October 7, 2009 at 3:08 pm

US-based Zydus Pharmaceuticals, a subsidiary of Zydus Cadila, has received final approval from the US Food and Drug Administration (USFDA) to market Ramipril tablets, in the strengths of 1.25 mg, 2.5 mg, 5 mg and 10 mg.
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor, used to treat hypertension and congestive heart failure.
Cadila Healthcare is the flagship [...]

For Full Story Click Here ...



keep looking »

  • Search

  • Investment Books

  • Smart Investment